IGF-1R inhibition sensitizes breast cancer cells to ATM-related kinase (ATR) inhibitor and cisplatin

Por O'Flanagan, Ciara H., O'shea, Sandra, Lyons, Amy, Fogarty, Fionola M., McCabe, Nuala, Kennedy, Richard D., O'Connor, Rosemary
Publicado no Oncotarget (2016)